Home Pharmaceuticals Exosomes Market Size, Top Share, and Industry Analysis Report to 2033

Exosomes Market Size, Share & Trends Analysis Report By Type (Natural Exosomes, Engineered Exosomes), By Isolation Method (Integrated Microfluidic, Asymmetric Flow Field-Flow Fractionation, Deterministic Lateral Displacement, Others), By Application (Drug Delivery, Disease Diagnosis, Tissue Repair, Others), By End-User  (Pharmaceutical and Biotechnology Companies, Hospitals, Diagnostics Centers, Academic and Research Institutions) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH57039DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Exosomes Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Natural Exosomes
        1. By Value
      3. Engineered Exosomes
        1. By Value
    3. By Isolation Method
      1. Introduction
        1. Isolation Method By Value
      2. Integrated Microfluidic
        1. By Value
      3. Asymmetric Flow Field-Flow Fractionation
        1. By Value
      4. Deterministic Lateral Displacement
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Delivery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Tissue Repair
        1. By Value
      5. Others
        1. By Value
    5. By End-User 
      1. Introduction
        1. End-User  By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostics Centers
        1. By Value
      5. Academic and Research Institutions
        1. By Value
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Natural Exosomes
        1. By Value
      3. Engineered Exosomes
        1. By Value
    3. By Isolation Method
      1. Introduction
        1. Isolation Method By Value
      2. Integrated Microfluidic
        1. By Value
      3. Asymmetric Flow Field-Flow Fractionation
        1. By Value
      4. Deterministic Lateral Displacement
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Delivery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Tissue Repair
        1. By Value
      5. Others
        1. By Value
    5. By End-User 
      1. Introduction
        1. End-User  By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostics Centers
        1. By Value
      5. Academic and Research Institutions
        1. By Value
    6. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Natural Exosomes
          1. By Value
        3. Engineered Exosomes
          1. By Value
      2. By Isolation Method
        1. Introduction
          1. Isolation Method By Value
        2. Integrated Microfluidic
          1. By Value
        3. Asymmetric Flow Field-Flow Fractionation
          1. By Value
        4. Deterministic Lateral Displacement
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Drug Delivery
          1. By Value
        3. Disease Diagnosis
          1. By Value
        4. Tissue Repair
          1. By Value
        5. Others
          1. By Value
      4. By End-User 
        1. Introduction
          1. End-User  By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostics Centers
          1. By Value
        5. Academic and Research Institutions
          1. By Value
    7. Canada
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Natural Exosomes
        1. By Value
      3. Engineered Exosomes
        1. By Value
    3. By Isolation Method
      1. Introduction
        1. Isolation Method By Value
      2. Integrated Microfluidic
        1. By Value
      3. Asymmetric Flow Field-Flow Fractionation
        1. By Value
      4. Deterministic Lateral Displacement
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Delivery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Tissue Repair
        1. By Value
      5. Others
        1. By Value
    5. By End-User 
      1. Introduction
        1. End-User  By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostics Centers
        1. By Value
      5. Academic and Research Institutions
        1. By Value
    6. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Natural Exosomes
          1. By Value
        3. Engineered Exosomes
          1. By Value
      2. By Isolation Method
        1. Introduction
          1. Isolation Method By Value
        2. Integrated Microfluidic
          1. By Value
        3. Asymmetric Flow Field-Flow Fractionation
          1. By Value
        4. Deterministic Lateral Displacement
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Drug Delivery
          1. By Value
        3. Disease Diagnosis
          1. By Value
        4. Tissue Repair
          1. By Value
        5. Others
          1. By Value
      4. By End-User 
        1. Introduction
          1. End-User  By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostics Centers
          1. By Value
        5. Academic and Research Institutions
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Natural Exosomes
        1. By Value
      3. Engineered Exosomes
        1. By Value
    3. By Isolation Method
      1. Introduction
        1. Isolation Method By Value
      2. Integrated Microfluidic
        1. By Value
      3. Asymmetric Flow Field-Flow Fractionation
        1. By Value
      4. Deterministic Lateral Displacement
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Delivery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Tissue Repair
        1. By Value
      5. Others
        1. By Value
    5. By End-User 
      1. Introduction
        1. End-User  By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostics Centers
        1. By Value
      5. Academic and Research Institutions
        1. By Value
    6. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Natural Exosomes
          1. By Value
        3. Engineered Exosomes
          1. By Value
      2. By Isolation Method
        1. Introduction
          1. Isolation Method By Value
        2. Integrated Microfluidic
          1. By Value
        3. Asymmetric Flow Field-Flow Fractionation
          1. By Value
        4. Deterministic Lateral Displacement
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Drug Delivery
          1. By Value
        3. Disease Diagnosis
          1. By Value
        4. Tissue Repair
          1. By Value
        5. Others
          1. By Value
      4. By End-User 
        1. Introduction
          1. End-User  By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostics Centers
          1. By Value
        5. Academic and Research Institutions
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Natural Exosomes
        1. By Value
      3. Engineered Exosomes
        1. By Value
    3. By Isolation Method
      1. Introduction
        1. Isolation Method By Value
      2. Integrated Microfluidic
        1. By Value
      3. Asymmetric Flow Field-Flow Fractionation
        1. By Value
      4. Deterministic Lateral Displacement
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Delivery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Tissue Repair
        1. By Value
      5. Others
        1. By Value
    5. By End-User 
      1. Introduction
        1. End-User  By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostics Centers
        1. By Value
      5. Academic and Research Institutions
        1. By Value
    6. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Natural Exosomes
          1. By Value
        3. Engineered Exosomes
          1. By Value
      2. By Isolation Method
        1. Introduction
          1. Isolation Method By Value
        2. Integrated Microfluidic
          1. By Value
        3. Asymmetric Flow Field-Flow Fractionation
          1. By Value
        4. Deterministic Lateral Displacement
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Drug Delivery
          1. By Value
        3. Disease Diagnosis
          1. By Value
        4. Tissue Repair
          1. By Value
        5. Others
          1. By Value
      4. By End-User 
        1. Introduction
          1. End-User  By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostics Centers
          1. By Value
        5. Academic and Research Institutions
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Natural Exosomes
        1. By Value
      3. Engineered Exosomes
        1. By Value
    3. By Isolation Method
      1. Introduction
        1. Isolation Method By Value
      2. Integrated Microfluidic
        1. By Value
      3. Asymmetric Flow Field-Flow Fractionation
        1. By Value
      4. Deterministic Lateral Displacement
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Drug Delivery
        1. By Value
      3. Disease Diagnosis
        1. By Value
      4. Tissue Repair
        1. By Value
      5. Others
        1. By Value
    5. By End-User 
      1. Introduction
        1. End-User  By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostics Centers
        1. By Value
      5. Academic and Research Institutions
        1. By Value
    6. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Natural Exosomes
          1. By Value
        3. Engineered Exosomes
          1. By Value
      2. By Isolation Method
        1. Introduction
          1. Isolation Method By Value
        2. Integrated Microfluidic
          1. By Value
        3. Asymmetric Flow Field-Flow Fractionation
          1. By Value
        4. Deterministic Lateral Displacement
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Drug Delivery
          1. By Value
        3. Disease Diagnosis
          1. By Value
        4. Tissue Repair
          1. By Value
        5. Others
          1. By Value
      4. By End-User 
        1. Introduction
          1. End-User  By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostics Centers
          1. By Value
        5. Academic and Research Institutions
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Exosomes Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Danaher
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Hologic Inc.
    3. NurExone Biologic Inc
    4. Lonza
    5. Miltenyi Biotec
    6. Bio-Techne Corporation
    7. QIAGEN
    8. Thermo Fisher Scientific, Inc.
    9. Abcam plc
    10. RoosterBio, Inc.
    11. CD Bioparticles.
    12. Sartorius AG
    13. Aethlon Medical, Inc. 
    14. ILIAS Biologics Inc.
    15. EXO Biologics
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
X-Ray Inspection System Market Size The global x-ray inspection system market size was valued at USD 834.65 million in 2024 and is expected to grow from USD 889.74 million in 2025 to reach USD 1483.61 million by 2033, growin
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :